BRIEF published on 04/30/2024 at 18:20, 1 year 7 months ago EUROPLASMA announces the postponement of the publication of the 2023 financial statements Financial Results Europlasma Postponed Publication Financial Statements 2023 Acquisition MG-Valdunes
BRIEF published on 04/24/2024 at 18:05, 1 year 7 months ago EUROPLASMA launches significant bond financing to support its growth Shareholder Dilution Europlasma Environment Railway Industry Bond Financing
BRIEF published on 04/19/2024 at 18:05, 1 year 7 months ago EUROPLASMA announces the drawing of the fourteenth tranche of its bond issue Investment Europlasma OCEANE Financial Risk Dilution Of Capital
BRIEF published on 04/17/2024 at 18:05, 1 year 7 months ago EUROPLASMA and Adomos end their exclusive discussions without final agreement Europlasma Negotiations Discussions Adomos Reconciliation
BRIEF published on 04/10/2024 at 07:35, 1 year 7 months ago EUROPLASMA announces a reverse stock split on Euronext Growth Europlasma Euronext Growth Dépollution Consolidation Of Actions Material Recovery
BRIEF published on 04/04/2024 at 16:23, 1 year 8 months ago EUROPLASMA publishes its total voting rights and shares as of March 31, 2024 Voting Rights Capital Europlasma Regulation Financial Markets
BRIEF published on 03/29/2024 at 11:35, 1 year 8 months ago EUROPLASMA announces a reduction of its capital to compensate for its losses Board Of Directors Europlasma Dépollution Capital Reduction General Assembly
BRIEF published on 03/20/2024 at 18:05, 1 year 8 months ago Validation by the Lille Court of the takeover offer of MG-Valdunes by Europlasma Europlasma MG-Valdunes Energetic Transition Railway Industry The Commercial Court
BRIEF published on 03/12/2024 at 18:05, 1 year 8 months ago EUROPLASMA announces the drawing of a new tranche of OCEANE for one million euros Europlasma OCEANE Dilution Bond Loan Waste Recovery
BRIEF published on 03/05/2024 at 14:13, 1 year 8 months ago EUROPLASMA announces its total number of voting rights and shares as of February 29, 2024 Voting Rights Capital Actions Europlasma Financial Markets
Published on 12/05/2025 at 02:35, 11 hours 1 minute ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 36 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 31 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 36 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 36 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 36 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 30 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 36 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 36 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 51 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 36 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 51 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 52 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health